The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy

The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy

The role of positron emission tomography (PET) with68 Gallium (Ga)-labeled prostate-specific membrane antigen (PSMA) imaging for prostate cancer is gaining prominence. Current imaging strategies, despite having progressed significantly, have limitations, in particular their ability to diagnose metas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Urology (Ridgewood, N.J.) N.J.), 2016
Hauptverfasser: Rai, Bhavan Prasad, Baum, Richard Paul, Patel, Amit, Hughes, Robert, Alonzi, Roberto, Lane, Tim, Adshead, Jim, Vasdev, Nikhil
Format: Artikel
Sprache:eng
Schlagworte:
Urology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title Urology (Ridgewood, N.J.)
container_volume
creator Rai, Bhavan Prasad
Baum, Richard Paul
Patel, Amit
Hughes, Robert
Alonzi, Roberto
Lane, Tim
Adshead, Jim
Vasdev, Nikhil
description The role of positron emission tomography (PET) with68 Gallium (Ga)-labeled prostate-specific membrane antigen (PSMA) imaging for prostate cancer is gaining prominence. Current imaging strategies, despite having progressed significantly, have limitations, in particular their ability to diagnose metastatic lymph node involvement. Preliminary results of PET with68 Ga-labeled PSMA have shown encouraging results, particularly in the recurrent prostate cancer setting. Furthermore, the ability of PET with68 Ga-labeled PSMA of playing a dual diagnostic and therapeutic setting (theranostics) is currently being investigated as well. PET with68 Ga-labeled PSMA certainly has a role to play in bridging some of the voids in contemporary prostate cancer imaging tools.
doi_str_mv 10.1016/j.urology.2015.12.048
format Article
fullrecord <record><control><sourceid>elsevier</sourceid><recordid>TN_cdi_elsevier_clinicalkeyesjournals_1_s2_0_S009042951600011X</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S009042951600011X</els_id><sourcerecordid>1_s2_0_S009042951600011X</sourcerecordid><originalsourceid>FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S009042951600011X3</originalsourceid><addsrcrecordid>eNqlkE9rwkAUxFNoofbPRyi8ox6S7qaa6qUQpLUHpaKB9haeyUtcu9mV3VXIt-9GKvTe075hZ-YHEwQPnEWc8eRxFx2Mlrpuo5jxUcTjiA3Hl0GPsQkLh_FkdB3cWLtjjCVJ8ty7CLItwUpLAl3BUlvhjFbw2ghrhT8y3eja4H7bwqdw22QMM5RSHBroz3AQznFDkkpYGm0dOgrtngpRiQIW1GwMKoJUOVGTgv5yvUgHIBQ4T1ygwpoaUu7ERSf8aU8M-DA1qrDQqhLKd6MqYa4Lj20hLY-oij9AmHbaeC20AadhhaXwXsgMoTv1d_m0ct50_juHC6eb9i64qlBauv99b4OXt9ds-h6SF0dBJi-kUF3um1qyO30wyvtynts4Z_m6G7bblSd-U86_nv5d8AMCO5XL</addsrcrecordid><sourcetype>Publisher</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Rai, Bhavan Prasad ; Baum, Richard Paul ; Patel, Amit ; Hughes, Robert ; Alonzi, Roberto ; Lane, Tim ; Adshead, Jim ; Vasdev, Nikhil</creator><creatorcontrib>Rai, Bhavan Prasad ; Baum, Richard Paul ; Patel, Amit ; Hughes, Robert ; Alonzi, Roberto ; Lane, Tim ; Adshead, Jim ; Vasdev, Nikhil</creatorcontrib><description>The role of positron emission tomography (PET) with68 Gallium (Ga)-labeled prostate-specific membrane antigen (PSMA) imaging for prostate cancer is gaining prominence. Current imaging strategies, despite having progressed significantly, have limitations, in particular their ability to diagnose metastatic lymph node involvement. Preliminary results of PET with68 Ga-labeled PSMA have shown encouraging results, particularly in the recurrent prostate cancer setting. Furthermore, the ability of PET with68 Ga-labeled PSMA of playing a dual diagnostic and therapeutic setting (theranostics) is currently being investigated as well. PET with68 Ga-labeled PSMA certainly has a role to play in bridging some of the voids in contemporary prostate cancer imaging tools.</description><identifier>ISSN: 0090-4295</identifier><identifier>DOI: 10.1016/j.urology.2015.12.048</identifier><language>eng</language><subject>Urology</subject><ispartof>Urology (Ridgewood, N.J.), 2016</ispartof><rights>Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids></links><search><creatorcontrib>Rai, Bhavan Prasad</creatorcontrib><creatorcontrib>Baum, Richard Paul</creatorcontrib><creatorcontrib>Patel, Amit</creatorcontrib><creatorcontrib>Hughes, Robert</creatorcontrib><creatorcontrib>Alonzi, Roberto</creatorcontrib><creatorcontrib>Lane, Tim</creatorcontrib><creatorcontrib>Adshead, Jim</creatorcontrib><creatorcontrib>Vasdev, Nikhil</creatorcontrib><title>The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy</title><title>Urology (Ridgewood, N.J.)</title><description>The role of positron emission tomography (PET) with68 Gallium (Ga)-labeled prostate-specific membrane antigen (PSMA) imaging for prostate cancer is gaining prominence. Current imaging strategies, despite having progressed significantly, have limitations, in particular their ability to diagnose metastatic lymph node involvement. Preliminary results of PET with68 Ga-labeled PSMA have shown encouraging results, particularly in the recurrent prostate cancer setting. Furthermore, the ability of PET with68 Ga-labeled PSMA of playing a dual diagnostic and therapeutic setting (theranostics) is currently being investigated as well. PET with68 Ga-labeled PSMA certainly has a role to play in bridging some of the voids in contemporary prostate cancer imaging tools.</description><subject>Urology</subject><issn>0090-4295</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNqlkE9rwkAUxFNoofbPRyi8ox6S7qaa6qUQpLUHpaKB9haeyUtcu9mV3VXIt-9GKvTe075hZ-YHEwQPnEWc8eRxFx2Mlrpuo5jxUcTjiA3Hl0GPsQkLh_FkdB3cWLtjjCVJ8ty7CLItwUpLAl3BUlvhjFbw2ghrhT8y3eja4H7bwqdw22QMM5RSHBroz3AQznFDkkpYGm0dOgrtngpRiQIW1GwMKoJUOVGTgv5yvUgHIBQ4T1ygwpoaUu7ERSf8aU8M-DA1qrDQqhLKd6MqYa4Lj20hLY-oij9AmHbaeC20AadhhaXwXsgMoTv1d_m0ct50_juHC6eb9i64qlBauv99b4OXt9ds-h6SF0dBJi-kUF3um1qyO30wyvtynts4Z_m6G7bblSd-U86_nv5d8AMCO5XL</recordid><startdate>2016</startdate><enddate>2016</enddate><creator>Rai, Bhavan Prasad</creator><creator>Baum, Richard Paul</creator><creator>Patel, Amit</creator><creator>Hughes, Robert</creator><creator>Alonzi, Roberto</creator><creator>Lane, Tim</creator><creator>Adshead, Jim</creator><creator>Vasdev, Nikhil</creator><scope/></search><sort><creationdate>2016</creationdate><title>The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy</title><author>Rai, Bhavan Prasad ; Baum, Richard Paul ; Patel, Amit ; Hughes, Robert ; Alonzi, Roberto ; Lane, Tim ; Adshead, Jim ; Vasdev, Nikhil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-elsevier_clinicalkeyesjournals_1_s2_0_S009042951600011X3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rai, Bhavan Prasad</creatorcontrib><creatorcontrib>Baum, Richard Paul</creatorcontrib><creatorcontrib>Patel, Amit</creatorcontrib><creatorcontrib>Hughes, Robert</creatorcontrib><creatorcontrib>Alonzi, Roberto</creatorcontrib><creatorcontrib>Lane, Tim</creatorcontrib><creatorcontrib>Adshead, Jim</creatorcontrib><creatorcontrib>Vasdev, Nikhil</creatorcontrib><jtitle>Urology (Ridgewood, N.J.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rai, Bhavan Prasad</au><au>Baum, Richard Paul</au><au>Patel, Amit</au><au>Hughes, Robert</au><au>Alonzi, Roberto</au><au>Lane, Tim</au><au>Adshead, Jim</au><au>Vasdev, Nikhil</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy</atitle><jtitle>Urology (Ridgewood, N.J.)</jtitle><date>2016</date><risdate>2016</risdate><issn>0090-4295</issn><abstract>The role of positron emission tomography (PET) with68 Gallium (Ga)-labeled prostate-specific membrane antigen (PSMA) imaging for prostate cancer is gaining prominence. Current imaging strategies, despite having progressed significantly, have limitations, in particular their ability to diagnose metastatic lymph node involvement. Preliminary results of PET with68 Ga-labeled PSMA have shown encouraging results, particularly in the recurrent prostate cancer setting. Furthermore, the ability of PET with68 Ga-labeled PSMA of playing a dual diagnostic and therapeutic setting (theranostics) is currently being investigated as well. PET with68 Ga-labeled PSMA certainly has a role to play in bridging some of the voids in contemporary prostate cancer imaging tools.</abstract><doi>10.1016/j.urology.2015.12.048</doi></addata></record>
fulltext fulltext
identifier ISSN: 0090-4295
ispartof Urology (Ridgewood, N.J.), 2016
issn 0090-4295
language eng
recordid cdi_elsevier_clinicalkeyesjournals_1_s2_0_S009042951600011X
source Elsevier ScienceDirect Journals Complete
subjects Urology
title The Role of Positron Emission Tomography With68 Gallium (Ga)-Labeled Prostate-specific Membrane Antigen (PSMA) in the Management of Patients With Organ-confined and Locally Advanced Prostate Cancer Prior to Radical Treatment and After Radical Prostatectomy
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T06%3A12%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Role%20of%20Positron%20Emission%20Tomography%20With68%20Gallium%20(Ga)-Labeled%20Prostate-specific%20Membrane%20Antigen%20(PSMA)%20in%20the%20Management%20of%20Patients%20With%20Organ-confined%20and%20Locally%20Advanced%20Prostate%20Cancer%20Prior%20to%20Radical%20Treatment%20and%20After%20Radical%20Prostatectomy&rft.jtitle=Urology%20(Ridgewood,%20N.J.)&rft.au=Rai,%20Bhavan%20Prasad&rft.date=2016&rft.issn=0090-4295&rft_id=info:doi/10.1016/j.urology.2015.12.048&rft_dat=%3Celsevier%3E1_s2_0_S009042951600011X%3C/elsevier%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=1_s2_0_S009042951600011X&rfr_iscdi=true